Clinical Trial Update: Prevention of Post-traumatic Seizures With Levetiracetam [Phase 3]

View source ↗

Summary

Phase 3 study evaluating levetiracetam to prevent post-traumatic seizures has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: Rennes University Hospital | Conditions: Epilepsy, Post-Traumatic | Phase 3 | Status: TERMINATED